CannyCann+ 20/1 Island Siesta is an evenly balanced hybrid strain (50% indica/50% sativa) of medicinal cannabis characterised by 20% THC and <1% CBD. With a blend of terpenes creating aromas of lemon and pine, this strain of medicinal cannabis offers relaxing effects.
This product may be suitable for patients with conditions including insomnia, chronic pain, stress, depression, anxiety and other conditions.
▼ Product Sheet
These results are based on the typical terpene profile of CannyCann+ T20:C1 (Island Siesta). Please note that whilst the terpene wheel indicates an exact percentage, this % is formulated from a recent batch and the terpene level of all medicinal cannabis will always vary batch by batch.
These DNA test results are personalised results, and should not be shared or recommended to anyone else. Patients seeking medicinal cannabis products should always seek advice by a specialist Doctor/s on the General Medical Council Specialist Register. Whilst these products have been recommended to match your individual DNA they can only be prescribed under the guidance of a specialist Doctor and approval from a multidisciplinary team.
